SpineGuard and Omnia Medical Announce the Extension of Their Strategic Partnership
OrthoSpineNews
JANUARY 7, 2025
SpineGuards and Omnia Medicals missions perfectly align as they both aim to make spine surgery safer and achieve superior surgical outcomes while reducing overall healthcare costs. On September 30, 2024, SpineGuard announced the 510k clearance by the FDA of its new PsiFGuard cannulated probe designed to secure sacroiliac implant placement.
52 
Let's personalize your content